Navigation Links
Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices
Date:8/19/2010

MINNEAPOLIS, Aug. 19 /PRNewswire-FirstCall/ -- Protectus Medical Devices, Inc. ("Protectus Medical Devices") (OTCQB: PTMD), a developer and marketer of innovative medical devices, today named physician/surgeon Dr. Dan Hartley as Medical Director.

Dr. Hartley has vast experience in research and development in pharmaceutical and medical device industries, including quality control, medical writing and regulatory compliance.  He has served as a clinical data auditor and has held senior level clinical research associate positions at several major pharmaceutical companies.

Dr. Hartley will establish the Protectus Medical Advisory Board, oversee quality control, compliance and assurance, and serve as a medical spokesperson helping to establish Protectus as the world leader in medical safety devices, such as its patented Safety Syringe.

The Protectus Safety Syringe is the only fully automatic, self-sheathing safety hypodermic syringe that currently meets all U.S. Federal Government and OSHA mandates designed to protect both healthcare workers and patients alike.  It is designed to significantly reduce or eliminate accidental needlestick injuries that have plagued the healthcare workplace for decades.  More information about Protectus Medical Devices may be found at the Company's corporate website at www.protectusmedical.com.

According to Protectus CEO and President Dr. John Salstroms, "Dr. Hartley will bring unmatched experience, passion, and commitment toward achieving our goal of developing the safest needle devices in the healthcare workplace to protect the health and well-being of workers and patients worldwide."

Dr. Hartley will be involved with a broad range of Protectus Safety Syringes, including: the Safety IV Catheter (patent-pending); Safety Dental Syringe (patent pending), both using the same patented safety designed engineering as the Safety Syringe, and soon to be announced Phlebotomy device.

About Protectus Medical Devices, Inc. (formerly, E-18 Corp.)Protectus Medical Devices, Inc. (PTMD, formerly, E-18 Corp.), through its wholly owned subsidiary, SquareOne Medical, Inc., develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim. Protectus Medical Devices has successfully patented its automatic, self-sheathing hypodermic safety syringe product, and, based on the results of full comparison clinical trials, the Protectus Safety Syringe (formerly the SquareOne Safety Syringe) has received the required 510(k) permission from the U.S. FDA to manufacture and market the device in the U.S. More information about the Company may be found at www.protectusmedical.com.

Forward-Looking StatementsThis release contains "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. These forward-looking statements are subject to various risks and uncertainties that could cause the business and financial results of Protectus Medical Devices, Inc. to differ materially from those currently anticipated, including the risk factors identified in Protectus Medical Devices, Inc.'s filings with the Securities and Exchange Commission.Company Contact:Protectus Medical Devices, Inc. John Salstrom, President and CEOPh: 1-800-778-8438moreinfo@protectusmedical.com
'/>"/>

SOURCE Protectus Medical Devices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others
2. Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care
3. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
4. Concord Medical Announces Second Quarter 2010 Financial Results
5. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
6. VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions
7. Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010
8. Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27
9. UCI Medical Affiliates, Inc. Reports Third Quarter Results for Fiscal Year 2010
10. Medco Announces Agreement to Acquire United BioSource Corporation: A Global Medical Research and Scientific Services Leader to Advance Drug Safety and Knowledge
11. China Medical Technologies Reports First Fiscal Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
(Date:6/9/2017)... , June 9, 2017 More than 400 ... effort to help spread lessons learned from clinical research ... Diabetes Federation (IDF) and Eli Lilly and Company (NYSE: ... second phase of the Bringing Research in Diabetes to ... commitment to helping people with diabetes effectively manage their ...
(Date:6/8/2017)... June 8, 2017  StatLab Medical Products ... and manufacturer of diagnostic supplies for the ... Cressey & Company LP ("Cressey & Company"), ... a growth-focused investment in the Company. Cressey ... position from selling shareholder, Prairie Capital, L.P., ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... ... heatwave currently bearing down on Northern California pushing temperatures to the maximum, many people are ... with laser hair removal. , The process of summer waxing and constantly shaving unwanted ... want to do is get out, dive in and cool off. There is a way ...
(Date:6/24/2017)... ... June 24, 2017 , ... The weather is heating up and ... and business owners should be aware that the summer months provide more than warmer ... locks and keys can be negatively affected from direct exposure to the sun. When ...
(Date:6/23/2017)... ... June 23, 2017 , ... Yesterday, U.S. Senate Republicans ... to repeal and replace the Affordable Care Act (ACA). Like the bill narrowly ... to Medicaid, a public health insurance program for low-income children, pregnant women, parents ...
(Date:6/23/2017)... ... June 23, 2017 , ... Everybody has their own personal preference when ... read it, and some people don't like it at all. FindaTopDoc took a look ... , Erotic literature can give readers a taste of their deepest, darkest fantasies and ...
(Date:6/23/2017)... ... ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows ... civil society in 11 countries across the Middle East and South Asia to embark ... of knowledge and ideas with the leading minds in their fields. , For ...
Breaking Medicine News(10 mins):